Journal of Viral Hepatitis

Cover image for Vol. 18 Issue 8

August 2011

Volume 18, Issue 8

Pages 525–600

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis (pages 525–532)

      C. Stasi, A. L. Zignego, G. Laffi and M. Rosselli

      Version of Record online: 7 JAN 2011 | DOI: 10.1111/j.1365-2893.2010.01418.x

      • image
      • image
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection (pages 533–541)

      K. England, C. Thorne, H. Harris, M. Ramsay and M.-L. Newell

      Version of Record online: 22 JUN 2011 | DOI: 10.1111/j.1365-2893.2011.01128.x

      • image
    2. Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis (pages 542–548)

      L. Martín-Carbonero, P. Tuma, E. Vispo, J. Medrano, P. Labarga, J. González-Lahoz, P. Barreiro and V. Soriano

      Version of Record online: 31 AUG 2010 | DOI: 10.1111/j.1365-2893.2010.01334.x

      • image
      • image
    3. Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users (pages 549–561)

      J. K. Flynn, G. J. Dore, M. Hellard, B. Yeung, W. D. Rawlinson, P. A. White, J. M. Kaldor, A. R. Lloyd, R. A. Ffrench and on behalf of the ATAHC Study Group

      Version of Record online: 5 JUL 2010 | DOI: 10.1111/j.1365-2893.2010.01335.x

      • image
      • image
      • image
      • image
      • image
    4. Hepatitis C virus enters human peripheral neuroblastoma cells – evidence for extra-hepatic cells sustaining hepatitis C virus penetration (pages 562–570)

      B. Bürgel, M. Friesland, A. Koch, M. P. Manns, H. Wedemeyer, K. Weissenborn, W. J. Schulz-Schaeffer, T. Pietschmann, E. Steinmann and S. Ciesek

      Version of Record online: 23 JUN 2010 | DOI: 10.1111/j.1365-2893.2010.01339.x

      • image
      • image
      • image
      • image
      • image
    5. Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients (pages 580–586)

      R. Moucari, N. Boyer, M.-P. Ripault, C. Castelnau, V. Mackiewicz, A. Dauvergne, D. Valla, M. Vidaud, M.-H. N. Chanoine and P. Marcellin

      Version of Record online: 17 MAY 2010 | DOI: 10.1111/j.1365-2893.2010.01332.x

      • image
      • image
      • image
      • image
    6. Study of cellular immune response against Hepatitis E Virus (HEV) (pages 587–594)

      S. B. Prabhu, P. Gupta, H. Durgapal, S. Rath, S. D. Gupta, S. K. Acharya and S. K. Panda

      Version of Record online: 23 JUN 2010 | DOI: 10.1111/j.1365-2893.2010.01338.x

      • image
      • image
      • image
      • image
    7. Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a (pages 595–600)

      Y. Q. Zhou, X. H. Wang, G. H. Hong, Y. Zhu, X. Q. Zhang, Y. J. Hu and Q. Mao

      Version of Record online: 24 NOV 2010 | DOI: 10.1111/j.1365-2893.2010.01373.x

      • image
      • image

SEARCH

SEARCH BY CITATION